Abstract
It’s probably safe to say there’s not a migraineur alive who hasn’t at least wished for a magic pill to cure the disorder. Most of us have actively sought such a remedy—some more frantically than others. Usually we have been at least somewhat disappointed in our search. For some sufferers, pursuing the magic cure will become a life-long preoccupation. For many others this quest will dramatically color, or perhaps even dominate, one or more decades of their lives. There’s not much that a severe sufferer would not try in order to avoid or interrupt an attack: An acquaintance recently told me she had tried everything but witch doctors. In past years when narcotics were often prescribed for severe pain, addiction was not an uncommon occurrence among migraineurs seeking relief from their misery. Even today certain migraine-relieving drugs can lead either to dependence or to rebound headache, and indeed—at least in the long run—may create more problems than they solve.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Suggested Readings/References
Suggested Readings
Alan M. Rapoport, MD and Fred D. Sheftell, MD, “Biofeedback: Learning to Monitor Yourself,” Headache Relief, Fireside, 1991.
Sidney Wolfe, MD and Rose-Ellen Hope, RPh, Worst Pills/Best Pills II: The Older Adult’s Guide to Avoiding Drug-Induced Death or Illness, Public Citizen Health Research Group, 1993.
References
W. K. Amery, MD, “Cerebral Hypoxia and Migraine,” in The Pharmacological Basis for Migraine Therapy, W. K. Amery, Ed., Pitman, 1984.
Robert Bell, MD, et al., “A Comparative Trial of Three Agents in the Treatment of Acute Migraine Headache,” Annals of Emergency Medicine, 10 Oct., 1990.
A. J. Bellavance, MD and J. P. Meloche, MD, “A Comprehensive Study of Naproxen Sodium, Pizotyline and Placebo in Migraine Prophylaxis,” Headache, Vol. 30, 1990.
J. N. Blau, MD, “Adult Migraine: The Patient Observed,” in Migraine: Clinical and Research Aspects, J. N. Blau, Ed., Johns Hopkins University Press, 1987.
J. N. Blau, MD, “Clinical Characteristics of Premonitory Symptoms in Migraine,” in The Prelude to the Migraine Attack, W. K. Amery, Ed., Saunders, 1986.
David D. Celentano, et al., “Medication Use and Disability Among Migraineurs: A National Probability Survey,” Headache, Vol. 32, 1992.
C. Dahlof, MD, “Flunarizine Versus Long-Acting Propranolol in the Prophylactic Treatment of Migraine,” in New Advances in Headache Research, F. C. Rose, MD, Ed., Smith-Gordon, 1989.
Vincent DeQuattro, MD, Mark Myers, MD, and Vito M. Campese, MD, “Anatomy and Biochemistry of the Sympathetic Nervous System,” in Endocrinology, Leslie J. DeGroot, MD, Ed., Saunders, 2nd Edition, 1989.
Seymour Diamond, MD, “Migraine Headaches,” in The Medical Clinics of North America, Seymour Diamond, Ed., Vol. 75, No. 3, 1991.
John Edmeads, MD, “Four Steps in Managing Migraine,” Postgraduate Medicine, Vol. 85, No. 6, 1989.
Frederick Freitag, MD and Seymour Diamond, MD, “The Longterm Use of Monoamine Oxidase Inhibitors in the Management of Headache,” in New Advances in Headache Research.
Edda Hanington, MD, “The Platelet Theory,” in Migraine: Clinical and Research Aspects.
H. Havanka-Kanniainen, MD, “Treatment of Acute Migraine Attack: Ibuprofen and Placebo Compared,” Headache, Vol. 29, 1989.
K. A. Holyroyd, MD, et al., “Propranolol in the Management of Recurrent Migraine: A Meta-Analytic Review,” Headache, Vol. 31, 1991.
Jeffrey Jones, MD, et al., “Randomized Double-Blind Trial of Intravenous Procholorperazine for the Treatment of Acute Headache,” Journal of the American Medical Association, Vol. 261, No. 8, 1989.
H. D. Langohr, MD, et al., “Clomipramine and Metoprolol in Migraine Prophylaxis: A Double-Blind Crossover Study,” Headache, Vol. 25, 1985.
H. G. Markley, MD, “Verapamil and Migraine Prophylaxis: Mechanisms and Efficacy,” The American Journal of Medicine, Vol. 90, No. 5A, 1991.
N. T. Mathew, MD, “Drug-Induced Headache,” Neurological Clinics, Vol. 8, No. 4, 1990.
Richard Peatfield, MD, “Drugs and the Treatment of Migraine,” Trends in Pharmacological Sciences, Vol. 9, 1988.
A. Pradalier, MD, et al., “Non-Steroidal Anti-Inflammatory Drugs in the Treatment of Long-Term Prevention of Migraine Attacks,” Headache, Vol. 28, 1988.
Hanna A. Saadah, MD, “Abortive Headache Therapy in the Office with Intravenous Dihydroergotamine Plus Prochlorperazine,” Headache, Vol. 32, 1992.
P. S. Sorensen, MD, et al., “Flunarizine Versus Metoprolol in Migraine Prophylaxis: A Double-Blind, Randomized Parallel Group Study of Efficacy and Tolcmbility,” Headache, Vol. 31, 1991.
Oksana Suchowersky, MD, “Rebound Headaches Due to Sumatriptan,” Neurology, Vol. 43, April, 1993.
D. S. Tek, MD, et al., “A Prospective, Double-Blind Study of Metoclopramine Hydrochloride for Migraine in the Emergency Department,” Annals of Emergency Medicine, Vol. 19, 1990.
Peer Tfelt-Hansen, H. D. Iversen, and Jes Olesen, MD, Letter to the Editors (Sumatriptan), Journal of the American Medical Association, Nov. 20, 1991.
Paul Turner, MD, “Beta-Adrenoceptor Blocking Drugs in the Prophylaxis of Migraine—A Critical Review,” in Migraine: Clinical and Research Aspects.
Sidney M. Wolfe, MD and Rose-Ellen Hope, RPh, “Mind Drugs: Tranquilizers, Sleeping Pills, Antipsychotics, and Antidepressants,” in Worst Pills/Best Pills II, Public Citizen Health Research Group, 1993.
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Burks, S.L. (1994). Getting Effective Treatment. In: Managing Your Migraine. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-4612-0305-6_10
Download citation
DOI: https://doi.org/10.1007/978-1-4612-0305-6_10
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-0-89603-324-5
Online ISBN: 978-1-4612-0305-6
eBook Packages: Springer Book Archive